.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Merck
McKesson
AstraZeneca
Dow
Harvard Business School
Medtronic
Colorcon
Johnson and Johnson

Generated: September 24, 2017

DrugPatentWatch Database Preview

NOLUDAR Drug Profile

« Back to Dashboard

What is the patent landscape for Noludar, and what generic Noludar alternatives are available?

Noludar is a drug marketed by Roche and is included in one NDA.

The generic ingredient in NOLUDAR is methyprylon. Additional details are available on the methyprylon profile page.

Summary for Tradename: NOLUDAR

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list9
Patent Applications: see list669
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NOLUDAR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
NOLUDAR
methyprylon
CAPSULE;ORAL009660-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
NOLUDAR
methyprylon
TABLET;ORAL009660-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
NOLUDAR
methyprylon
ELIXIR;ORAL009660-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
NOLUDAR
methyprylon
TABLET;ORAL009660-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Daiichi Sankyo
Fish and Richardson
Farmers Insurance
Chubb
Federal Trade Commission
Citi
Fuji
UBS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot